MRI detected mass decrease in patients with amyloidosis after treatment with green tea: a one year follow-up study by Buss, Sebastian et al.
POSTER PRESENTATION Open Access
MRI detected mass decrease in patients with
amyloidosis after treatment with green tea: a one
year follow-up study
Sebastian Buss
*, Arnt Kristen, Stephanie Lehrke, Hugo A Katus
From 15th Annual SCMR Scientific Sessions
Orlando, FL, USA. 2-5 February 2012
Background
Amyloidosis (AM) is a disease complex that results from
extra-cellular protein deposition of uniquely twisted and
insoluble beta pleated sheet fibrils that can be found in
several acquired or hereditary AM forms. Clinically
apparent cardiac involvement can be seen in about 30%
of patients resulting in a restrictive cardiomyopathy,
which is the most common cause of death in these
patients. Recently, there was compelling evidence that
polyphenol epigallo-catechin-3-gallate (EGCG), a chemi-
cal component of regular green tea, induces aggregation
products that do not polymerize into fibrils. Cardiac
MRI is the reference standard for measurement of car-
diac function, myocardial mass and cardiac remodeling
but has not been used for longitudinal follow-up of AM
patients treated with EGCG.
We hypothesized that cardiac MRI is able to detect
changes in cardiac function, myocardial mass and LV
remodeling in AM patients being treated with EGCG
for 12 months.
Methods
In a twelve-month follow-up, we studied 12 patients (70
±7 ys, 2 women) with acquired or genetic forms of AM
using a whole body 1.5T CMR scanner (Philips
Achieva). Vector-ECG gated short axis, two and four
chamber cine slices with parallel image acquisition cov-
ering the entire left ventricle (LV) were acquired using a
regular SSFP sequence. LV volumes and myocardial
mass were acquired by manual drawing of endo- and
epicardial borders. In a blinded fashion, two observers at
different time-points assessed twice left ventricular (LV)
end-diastolic and systolic volumes (LVEDV, LVESV),
stroke volume (LVSV), ejection fraction (LVEF) and
longitudinal shortening. P<0.05 was considered statisti-
cally significant.
Results
Results are shown in Table 1. After twelve months,
there was a highly significant reduction in LV mass, a
significant increase in EDV, whereas EF, ESV and SV,
although marginal, did not reach statistical significance.
Conclusions
In a small study cohort of AM patients treated with
EGCG, our results provide preliminary evidence that
after a twelve month period of treatment, myocardial
mass was significantly reduced, although myocardial
function was primarily unaffected. The molecular
mechanisms- whether EGCG can elutriate existing
extracellular fibrils or whether it modifies the deficient
proteins avoiding the extracellular precipitation- as well
as the clinical relevance regarding modified risk stratifi-
cation, future cardiac events and event-free survival war-
rant further investigation in a much larger patient
cohort.
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Table 1
MR Parameters Pre EGCG Std. Post EGCG Std. Significance
LV mass (g) 181 48 158 42 <0.01
LV EF (%) 57 14 57 11 n.s.
LVEDV (ml) 170 57 175 50 0.05
LVESV (ml) 77 44 79 48 0.07
LVSV (ml) 94 29 96 11 0.08
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